Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M Amabile

CD34+/Ph+ Cells Are Still Detectable in Chronic Myeloid Leukemia Patients With Sustained and Prolonged Complete Cytogenetic Remission During Treatment With Imatinib Mesylate

Leukemia

English

Concamitant Expression of the Rare E1/A3 and B2/A3 Types of BCR/ABL Transcript in a Chronic Myeloid Leukemia (CML) Patient

English

Related publications

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Haematologica

Hematology

2010

English

Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia

Haematologica

Hematology

2019

English

Development of Multiple Myeloma in a Patient With Chronic Myeloid Leukemia After Treatment With Imatinib Mesylate

English

Functional Activity of Cd34-Positive Cells in Chronic Myeloid Leukemia Patients With Different Response to Imatinib Therapy

Experimental Oncology

Cancer Research

Oncology

2015

English

Alterations in Creatine Kinase, Phosphate and Lipid Values in Patients With Chronic Myeloid Leukemia During Treatment With Imatinib

Haematologica

Hematology

2008

English

In Vitro Effects of Imatinib on CD34+ Cells of Patients With Chronic Myeloid Leukemia in the Megakaryocytic Crisis Phase

English

Demonstration of Philadelphia Chromosome Negative Abnormal Clones in Patients With Chronic Myelogenous Leukemia During Major Cytogenetic Responses Induced by Imatinib Mesylate

English

Long-Term Molecular Responses to Imatinib in Patients With Chronic Myeloid Leukemia: Comparison Between Complete Cytogenetic Responders Treated in Early and in Late Chronic Phase

Haematologica

Hematology

2007

English

Chromosomal Abnormalities in Philadelphia Chromosome Negative Metaphases Appearing During Imatinib Mesylate Therapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M Amabile

CD34+/Ph+ Cells Are Still Detectable in Chronic Myeloid Leukemia Patients With Sustained and Prolonged Complete Cytogenetic Remission During Treatment With Imatinib Mesylate

Concamitant Expression of the Rare E1/A3 and B2/A3 Types of BCR/ABL Transcript in a Chronic Myeloid Leukemia (CML) Patient

Related publications

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia

Development of Multiple Myeloma in a Patient With Chronic Myeloid Leukemia After Treatment With Imatinib Mesylate

Functional Activity of Cd34-Positive Cells in Chronic Myeloid Leukemia Patients With Different Response to Imatinib Therapy

Alterations in Creatine Kinase, Phosphate and Lipid Values in Patients With Chronic Myeloid Leukemia During Treatment With Imatinib

In Vitro Effects of Imatinib on CD34+ Cells of Patients With Chronic Myeloid Leukemia in the Megakaryocytic Crisis Phase

Demonstration of Philadelphia Chromosome Negative Abnormal Clones in Patients With Chronic Myelogenous Leukemia During Major Cytogenetic Responses Induced by Imatinib Mesylate

Long-Term Molecular Responses to Imatinib in Patients With Chronic Myeloid Leukemia: Comparison Between Complete Cytogenetic Responders Treated in Early and in Late Chronic Phase

Chromosomal Abnormalities in Philadelphia Chromosome Negative Metaphases Appearing During Imatinib Mesylate Therapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase